Janus-faced course of COVID-19 infection in patients with hematological malignancies

Eur J Haematol. 2020 Oct;105(4):502-504. doi: 10.1111/ejh.13470. Epub 2020 Jul 2.

Authors

Rosa Bellmann-Weiler¹, Francesco Burkert¹, Theresa Schwaiger², Stephan Schmidt², Christof Ludescher³, Horst Oexle⁴, Dominik Wolf², Günter Weiss¹

Affiliations

¹ Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
² Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Austria.
³ Outpatient Clinic for Hematology and Oncology, Innsbruck, Austria.
⁴ Department of Internal Medicine, District Hospital Hall, Hall, Austria.

No abstract available

Keywords: acute myeloid leukemia; immunology and infectious diseases; non-Hodgkin's lymphoma.

Publication types

Case Reports

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
COVID-19 / complications*
COVID-19 / immunology
Colonic Neoplasms
Comorbidity
Cytokine Release Syndrome / etiology
Cytokine Release Syndrome / prevention & control
Humans
Hypoxia / etiology*
Hypoxia / therapy
Immunocompromised Host
Immunosuppression Therapy*
Leukemia, Hairy Cell / complications*
Leukemia, Hairy Cell / drug therapy
Leukemia, Hairy Cell / immunology
Leukemia, Myeloid, Acute / complications*
Leukemia, Myeloid, Acute / drug therapy
Leukemia, Myeloid, Acute / immunology
Lymphoma, B-Cell / complications*
Lymphoma, B-Cell / drug therapy
Lymphoma, B-Cell / immunology
Lymphoma, Follicular / complications*
Lymphoma, Follicular / drug therapy
Lymphoma, Follicular / immunology
Male
Neoplasms, Second Primary / complications
Oxygen Inhalation Therapy
Pandemics
Recurrence
Respiration, Artificial
SARS-CoV-2